KINGCHEM (LIAONING) LIFE SCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.62 CNY | +0.62% |
|
-3.83% | -16.59% |
| Apr. 24 | Kingchem Life Science Co., Ltd Approves the Cash Dividend for the Year 2023 | CI |
| Apr. 23 | Kingchem Life Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 5,432 |
| Enterprise Value (EV) 1 | 4,886 |
| P/E ratio | 26.1 x |
| Yield | 1.27% |
| Capitalization / Revenue | 7.08 x |
| EV / Revenue | 6.37 x |
| EV / EBITDA | 19.1 x |
| EV / FCF | -5.57 x |
| FCF Yield | -18% |
| Price to Book | 2.5 x |
| Nbr of stocks (in thousands) | 120,447 |
| Reference price 2 | 45.10 |
| Announcement Date | 4/1/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 415.3 | 464.4 | 549.2 | 716.7 | 766.8 |
| EBITDA 1 | 102.3 | 115.1 | 135.1 | 218.8 | 256.4 |
| EBIT 1 | 70.71 | 79.47 | 92.45 | 167.4 | 191 |
| Operating Margin | 17.03% | 17.11% | 16.83% | 23.36% | 24.91% |
| Earnings before Tax (EBT) 1 | 69.51 | 68.71 | 99.84 | 193.8 | 203.4 |
| Net income 1 | 58.16 | 58.94 | 84.55 | 161.5 | 173.6 |
| Net margin | 14% | 12.69% | 15.4% | 22.53% | 22.64% |
| EPS 2 | 0.8286 | 0.8419 | 0.9423 | 1.784 | 1.729 |
| Free Cash Flow 1 | 3.435 | 47.67 | -191 | 53.95 | -877.9 |
| FCF margin | 0.83% | 10.26% | -34.77% | 7.53% | -114.48% |
| FCF Conversion (EBITDA) | 3.36% | 41.43% | - | 24.66% | - |
| FCF Conversion (Net income) | 5.91% | 80.88% | - | 33.41% | - |
| Dividend per Share | - | - | - | - | 0.5714 |
| Announcement Date | 5/9/22 | 5/9/22 | 5/9/22 | 7/13/23 | 4/1/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | 2.29 | - | - | - | - |
| Net Cash position 1 | - | 192 | 138 | 248 | 546 |
| Leverage (Debt/EBITDA) | 0.0224 x | - | - | - | - |
| Free Cash Flow 1 | 3.44 | 47.7 | -191 | 53.9 | -878 |
| ROE (net income / shareholders' equity) | 19.5% | 14% | 13.9% | 20.4% | 11.4% |
| ROA (Net income/ Total Assets) | 9.14% | 7.71% | 6.9% | 9.93% | 6.78% |
| Assets 1 | 636.2 | 764.9 | 1,226 | 1,626 | 2,560 |
| Book Value Per Share 2 | 4.670 | 5.720 | 7.790 | 9.730 | 18.00 |
| Cash Flow per Share 2 | 1.150 | 2.970 | 2.360 | 2.560 | 4.040 |
| Capex 1 | 43.8 | 86.9 | 171 | 127 | 72.9 |
| Capex / Sales | 10.54% | 18.72% | 31.07% | 17.68% | 9.51% |
| Announcement Date | 5/9/22 | 5/9/22 | 5/9/22 | 7/13/23 | 4/1/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -16.59% | 626M | |
| +34.35% | 705B | |
| +30.87% | 583B | |
| -3.49% | 364B | |
| +20.15% | 332B | |
| +6.19% | 291B | |
| +14.81% | 238B | |
| -3.44% | 210B | |
| +10.19% | 209B | |
| +9.21% | 169B |
- Stock Market
- Equities
- 301509 Stock
- Financials Kingchem (Liaoning) Life Science Co., Ltd.
